BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trentini MM, das Neves RC, Santos BP, DaSilva RA, de Souza AC, Mortari MR, Schwartz EF, Kipnis A, Junqueira-Kipnis AP. Non-disulfide-Bridge Peptide 5.5 from the Scorpion Hadrurus gertschi Inhibits the Growth of Mycobacterium abscessus subsp. massiliense. Front Microbiol 2017;8:273. [PMID: 28275372 DOI: 10.3389/fmicb.2017.00273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K. Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. PLoS One 2021;16:e0260003. [PMID: 34780520 DOI: 10.1371/journal.pone.0260003] [Reference Citation Analysis]
2 da Mata ECG, Ombredane A, Joanitti GA, Kanzaki LIB, Schwartz EF. Antiretroviral and cytotoxic activities of Tityus obscurus synthetic peptide. Arch Pharm (Weinheim) 2020;353:e2000151. [PMID: 32686134 DOI: 10.1002/ardp.202000151] [Reference Citation Analysis]
3 Cesa-Luna C, Muñoz-Rojas J, Saab-Rincon G, Baez A, Morales-García YE, Juárez-González VR, Quintero-Hernández V. Structural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria. PLoS One 2019;14:e0222438. [PMID: 31710627 DOI: 10.1371/journal.pone.0222438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Marques-Neto LM, Trentini MM, das Neves RC, Resende DP, Procopio VO, da Costa AC, Kipnis A, Mortari MR, Schwartz EF, Junqueira-Kipnis AP. Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis. Toxins (Basel) 2018;10:E219. [PMID: 29848960 DOI: 10.3390/toxins10060219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Luo X, Ye X, Ding L, Zhu W, Zhao Z, Luo D, Liu N, Sun L, Chen Z. Identification of the scorpion venom-derived antimicrobial peptide Hp1404 as a new antimicrobial agent against carbapenem-resistant Acinetobacter baumannii. Microb Pathog 2021;157:104960. [PMID: 34022355 DOI: 10.1016/j.micpath.2021.104960] [Reference Citation Analysis]
6 Jiang M, Ma L, Huang Y, Wu H, Dou J, Zhou C. Antimicrobial activities of peptide Cbf-K16 against drug-resistant Helicobacter pylori infection in vitro and in vivo. Microb Pathog 2020;138:103847. [PMID: 31704464 DOI: 10.1016/j.micpath.2019.103847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Bento CM, Gomes MS, Silva T. Looking beyond Typical Treatments for Atypical Mycobacteria. Antibiotics (Basel) 2020;9:E18. [PMID: 31947883 DOI: 10.3390/antibiotics9010018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]